The GLP is committed to full transparency. Download and review our Annual Report.

Genetic variant linked to variation in patient reponse to blood thinner

| | June 10, 2013

The following is an excerpt.

The discovery of a genetic variation in some blacks that affects response to the blood thinner warfarin may improve the safety and efficacy of the drug, as the era of personalized medicine approaches.

The needed dose of warfarin for blacks with the genetic variation is significantly lower than for those without it, the researchers reported online Tuesday in The Lancet.

Read the full story here: Medicine Gets Personal: Blacks Who Carry Genetic Variant May Need Lower Doses Of Blood Thinner

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend